Hosted on MSN13m
Piper Sandler Initiates Coverage of Monopar Therapeutics (MNPR) with Overweight RecommendationFintel reports that on January 10, 2025, Piper Sandler initiated coverage of Monopar Therapeutics (NasdaqCM:MNPR) with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback